← FDA Drug Approvals (Drugs@FDA)

VISIPAQUE 270

NDA · New Drug Application · Sponsor: GE HEALTHCARE · Approved 1996-03-22

Drug application

FDA Application #

NDA020351

Application type

New Drug Application

Brand name

VISIPAQUE 270

Generic name

IODIXANOL

Active ingredients

IODIXANOL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GE HEALTHCARE

Manufacturer

GE Healthcare Inc.

First approval

1996-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown